How has MiMedx Group's indefinite- lived intangible impairment changed year-over-year?

MiMedx Group's indefinite- lived intangible impairment increased by 2.5% year-over-year, from $25.3M to $25.94M.

What is the long-term trend for MiMedx Group's indefinite- lived intangible impairment?

Over 5 years (2020 to 2025), MiMedx Group's indefinite- lived intangible impairment has grown at a 23.5% compound annual growth rate (CAGR), from $13.34M to $38.36M.

MiMedx Group MDXG Indefinite- lived intangible impairment

Indefinite- lived intangible impairment at other companies

AxogenAXGN

——

Establishment LabsESTA

——

ICU MedicalICUI

——

Medline, Inc. MDLN

——

Other financials

Income statement

See full

Revenue$59.0M-33.1%

Gross profit$41.6M-41.9%

Operating income-$16.0M-295%

Net income-$10.9M-255%

EPS (diluted)-$0.07-240%

Balance sheet

See full

Cash & equivalents$159.8M+50.1%

Total debt$17.6M-5.7%

Total equity$242.9M+19.8%

Total assets$308.7M+14.1%

Cash flow

See full

Operating cash flow$1.9M-64.5%

CapEx$570.0K+51.2%

Free cash flow$1.3M-73.4%

Valuation

See full

Market cap$567.48M-33.9%

Enterprise value$425.3M-44.8%

P/E18.5×-2.9×

P/S1.5×-1.0×

Profitability

See full

Gross margin81%-0.9pp

Operating margin10.2%-5.1pp

Net margin7.9%-3.5pp

FCF margin17.8%-0.5pp

Returns & leverage

See full

Return on equity13.8%-8.6pp

Debt / equity0.1×0.0×

Current ratio5.4×+0.7×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsGrossExcludingGoodwill.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's indefinite- lived intangible impairment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MiMedx Group's indefinite- lived intangible impairment?: MiMedx Group (MDXG) reported indefinite- lived intangible impairment of $25.94M in Q1 2026.
How has MiMedx Group's indefinite- lived intangible impairment changed year-over-year?: MiMedx Group's indefinite- lived intangible impairment increased by 2.5% year-over-year, from $25.3M to $25.94M.
What is the long-term trend for MiMedx Group's indefinite- lived intangible impairment?: Over 5 years (2020 to 2025), MiMedx Group's indefinite- lived intangible impairment has grown at a 23.5% compound annual growth rate (CAGR), from $13.34M to $38.36M.